We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
+0.37%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$403M
AUM Growth
-$4.68M
Cap. Flow
-$2.76M
Cap. Flow %
-0.68%
Top 10 Hldgs %
28.94%
Holding
118
New
3
Increased
17
Reduced
54
Closed
2

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$3.56M
2
ADBE icon
Adobe
ADBE
+$1.61M
3
TSLA icon
Tesla
TSLA
+$422K
4
AFL icon
Aflac
AFL
+$199K
5
WEC icon
WEC Energy
WEC
+$194K

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$1.52M
2
IVV icon
iShares Core S&P 500 ETF
IVV
+$1.09M
3
QRVO icon
Qorvo
QRVO
+$877K
4
ABT icon
Abbott
ABT
+$388K
5
JPM icon
JPMorgan Chase
JPM
+$326K

Sector Composition

Rank Sector Weight
1 Technology 14.02%
2 Consumer Staples 11.95%
3 Healthcare 11.84%
4 Financials 10.61%
5 Industrials 10.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IEMG icon
26
iShares Core MSCI Emerging Markets ETF
IEMG
$152B
$5.69M 1.41%
105,487
+545
+0.5% +$29.3K
LH icon
27
Labcorp
LH
$24.9B
$5.67M 1.41%
24,365
-972
-4% -$236K
MRK icon
28
Merck
MRK
$316B
$5.64M 1.4%
62,886
-1,190
-2% -$111K
KO icon
29
Coca-Cola
KO
$374B
$5.51M 1.37%
76,977
-1,373
-2% -$91.7K
DUK icon
30
Duke Energy
DUK
$96.9B
$5.43M 1.35%
44,527
-1,435
-3% -$164K
NEE icon
31
NextEra Energy
NEE
$181B
$5.3M 1.32%
74,778
+56
+0.1% +$3.95K
PEP icon
32
PepsiCo
PEP
$191B
$5.26M 1.31%
35,067
+149
+0.4% +$22.2K
IEFA icon
33
iShares Core MSCI EAFE ETF
IEFA
$191B
$5.21M 1.29%
68,922
+29
+0% +$2.17K
DHI icon
34
D.R. Horton
DHI
$41B
$5.09M 1.26%
40,018
-435
-1% -$58.3K
LMT icon
35
Lockheed Martin
LMT
$135B
$4.96M 1.23%
11,116
-90
-0.8% -$41.4K
SYY icon
36
Sysco
SYY
$40.7B
$4.93M 1.22%
65,724
-805
-1% -$59K
CMCSA icon
37
Comcast
CMCSA
$87.2B
$4.89M 1.21%
132,574
+751
+0.6% +$27.1K
VZ icon
38
Verizon
VZ
$197B
$4.7M 1.17%
103,655
-2,845
-3% -$118K
TMO icon
39
Thermo Fisher Scientific
TMO
$212B
$4.63M 1.15%
9,315
+17
+0.2% +$9.21K
DIS icon
40
Walt Disney
DIS
$170B
$4.6M 1.14%
46,635
-473
-1% -$50.8K
XLE icon
41
State Street Energy Select Sector SPDR ETF
XLE
$38.5B
$4.51M 1.12%
96,542
-2,210
-2% -$99.6K
ADBE icon
42
Adobe
ADBE
$99.9B
$4.49M 1.12%
11,711
+3,755
+47% +$1.61M
UPS icon
43
United Parcel Service
UPS
$90.8B
$4.37M 1.08%
39,692
-1,067
-3% -$128K
MDT icon
44
Medtronic
MDT
$111B
$4.36M 1.08%
48,501
-2,367
-5% -$212K
NVDA icon
45
NVIDIA
NVDA
$5.01T
$4.24M 1.05%
39,120
+28,100
+255% +$3.56M
IWM icon
46
iShares Russell 2000 ETF
IWM
$81.5B
$4.19M 1.04%
21,008
-33
-0.2% -$7.16K
CTAS icon
47
Cintas
CTAS
$81.6B
$4.17M 1.03%
20,270
-1,030
-5% -$205K
OMC icon
48
Omnicom Group
OMC
$21.7B
$4.14M 1.03%
49,926
-1,439
-3% -$120K
SPY icon
49
State Street SPDR S&P 500 ETF Trust
SPY
$806B
$3.97M 0.99%
7,094
-22
-0.3% -$12.9K
USB icon
50
US Bancorp
USB
$99.6B
$3.93M 0.98%
93,093
-1,448
-2% -$66.8K

Similar funds

Boston Research & Management's Q1 2025 Portfolio in Review

As of Q1 2025, Boston Research & Management held 118 positions worth $403M, down 1.1% from $407M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Trading was light in Q1 2025: portfolio turnover was 4.2%. Boston Research & Management opened 3 new positions and exited 2, leaving the 118-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Consumer Staples and Healthcare.

  • Boston Research & Management's largest Q1 2025 buy was Tesla: 1,265 shares worth $327K.
  • Boston Research & Management added most to NVIDIA in Q1 2025, an estimated $3.56M increase.
  • Boston Research & Management's biggest Q1 2025 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.09M.
  • Boston Research & Management fully exited CVS Health in Q1 2025, selling an estimated $1.52M.
  • Boston Research & Management's ten largest holdings make up 29% of its $403M portfolio in Q1 2025.
  • Boston Research & Management opened 3 new positions and closed 2 in Q1 2025.
  • Boston Research & Management's portfolio value fell 1.1% quarter-over-quarter to $403M.

Based on Boston Research & Management's 13F filing for Q1 2025, filed 12 May 2025.